CBO of one of Europe's largest science and technology parks calls for richer female specific data sets to enable more informed and personalised healthcare.

On the back of the Pandemic, life sciences are riding high. The speed at which vaccines have been developed and supply chains built has shown the potential and agility of this sector. Last year the UK’s biotech industries attracted £4.5bn in funding – a rise of £1.7bn on the 2020 figure, with Venture Capital companies, who historically were nervous of the risks involved, now investing at record levels.